THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Researchers are working on a stem cell-based retinal implant that could be used for people with with advanced dry age-related macular degeneration. (Photo/ Britney O. Pennington) When Anna Kuehl began losing her vision, she feared losing the ability to read and go on long walks in … Continue reading How a tiny patch is helping restore lasting vision
Mark Humayun
CIRM funded trial for AMD shows promising results
This upcoming July is healthy vision month, a time to remember the importance of making vision and eye health a priority. It's also a time to think about the approximately 12 million people, 40 and over in the United States, that have a vision impairment. Vision can be something that many of us take for … Continue reading CIRM funded trial for AMD shows promising results
CIRM-funded study helps unlock some of the genetic secrets behind macular degeneration
Retina affected by age-related macular degeneration Age-related macular degeneration (AMD) is the leading cause of vision loss in people over 60. It affects 10 million Americans. That’s more than cataracts and glaucoma combined. The causes of AMD are not known but are believed to involve a mixture of hereditary and environmental factors. There is no … Continue reading CIRM-funded study helps unlock some of the genetic secrets behind macular degeneration
The moment of truth. A video about the stem cell therapy that could help millions of people going blind.
“No matter how much one prepares, the first patient is always something very special.” That’s how Dr. Mark Humayun describes his feelings as he prepared to deliver a CIRM-funded stem cell therapy to help someone going blind from dry age-related macular degeneration (AMD). Humayun, an ophthalmologist and stem cell researcher at USC, spent years developing … Continue reading The moment of truth. A video about the stem cell therapy that could help millions of people going blind.
Encouraging news about CIRM-funded clinical trial targeting vision loss
Dry age-related macular degeneration (AMD) is the leading cause of vision loss in the U.S. By 2020 it’s estimated that as many as three million Americans will be affected by the disease. Right now, there is no effective therapy. But that could change. A new CIRM-funded clinical trial is showing promise in helping people battling … Continue reading Encouraging news about CIRM-funded clinical trial targeting vision loss
Three people left blind by Florida clinic’s unproven stem cell therapy
The report makes for chilling reading. Three women, all suffering from macular degeneration – the leading cause of vision loss in the US – went to a Florida clinic hoping that a stem cell therapy would save their eyesight. Instead, it caused all three to go blind. The study, in the latest issue of the … Continue reading Three people left blind by Florida clinic’s unproven stem cell therapy
Seeing is believing: how some scientists – including two funded by CIRM – are working to help the blind see
“A pale hue”. For most of us that is a simple description, an observation about color. For Kristin Macdonald it’s a glimpse of the future. In some ways it’s a miracle. Kristin lost her sight to retinitis pigmentosa (RP). For many years she was virtually blind. But now, thanks to a clinical trial funded by … Continue reading Seeing is believing: how some scientists – including two funded by CIRM – are working to help the blind see
National honor for helping “the blind see”
Those of us fortunate to have good health take so many things for granted, not the least of which is our ability to see. But, according to the World Health Organization, there are 39 million people worldwide who are blind, and another 246 million who are visually impaired. Any therapy, any device, that can help … Continue reading National honor for helping “the blind see”
The Stem Cellar 